Ciencias de la Salud

Permanent URI for this communityhttp://repositorio.uta.edu.ec/handle/123456789/813

Browse

Filters

20251

Settings

Author: search.filters.author.Chimbo Yépez, Jenny FernandaSubject: search.filters.subject.RESISTENCIA A LA INSULINA

Search Results

Now showing 1 - 1 of 1
  • No Thumbnail Available
    Item
    DIAGNÓSTICO DEL SÍNDROME METABÓLICO EN PACIENTES CON SÍNTOMAS DEPRESIVOS DEL GADM BAÑOS DE AGUA SANTA
    (2025-02-24) Chimbo Yépez, Jenny Fernanda; Pérez Laborde, Elena Johanna; Universidad Técnica de Ambato/ Facultad de Ciencias de Salud /Carrera de Laboratorio Clínico
    Introduction:Metabolic syndrome is a cluster of interrelated conditions characterized by abdominal obesity, insulin resistance, dyslipidemia (elevated triglycerides and decreased highdensity lipoproteins), and hypertension. On the other hand, depressive symptoms are mood disorders that significantly affect an individual's quality of life. Several studies suggest a bidirectional relationship between both conditions, mediated by biological, social, and psychological mechanisms. Objective: To evaluate the association between metabolic syndrome in patients presenting depressive symptoms in the Municipal Government of Baños de Agua Santa. Methodology: A cross-sectional, descriptive, observational, and prospective study. The sample was selected using non-probabilistic convenience sampling, applying inclusion and exclusion criteria with a total of 75 participants belonging to the GADM Baños de Agua Santa. The Beck Depression Inventory-II was applied to measure depressive symptomatology, and the IDF criteria were used to diagnose the presence of MS. For statistical analysis, descriptive statistics and tests such as Chi-square and Cramer's V were applied. Results: 40.0% (30/75) of the participants presented metabolic syndrome. Additionally, a prevalence of 36.0% of mild depressive symptoms was observed in people with metabolic syndrome, while in individuals without this syndrome, depressive symptomatology of 37.3% was recorded. No significant association was found between several components of metabolic syndrome, such as glucose levels, diastolic blood pressure, and abdominal obesity, and depressive symptoms. However, a significant association was identified between insulin resistance (IR), elevated body mass index (BMI), HDL cholesterol (c-HDL) levels, and triglycerides (TG) with depressive symptoms (p < 0.05). Conclusion: There is a positive association of considerable magnitude between depressive symptoms and MS, indicating a multifactorial interaction between metabolic alterations and mood state.